Article info

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

Authors

  1. Correspondence to Prof Bernard Combe, Rheumatology, CHU Montpellier, 34295 Montpellier, France; bernard.combe{at}umontpellier.fr
View Full Text

Citation

Combe B, Kivitz A, Tanaka Y, et al
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

Publication history

  • Received September 30, 2020
  • Revised January 5, 2021
  • Accepted January 6, 2021
  • First published January 27, 2021.
Online issue publication 
June 17, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.